The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-(dimethylamino)ethyl)-4-(6H-indolo[2,3-b]quinoxalin-6-yl)butanamide ID: ALA4086523
PubChem CID: 137642447
Max Phase: Preclinical
Molecular Formula: C22H25N5O
Molecular Weight: 375.48
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)CCNC(=O)CCCn1c2ccccc2c2nc3ccccc3nc21
Standard InChI: InChI=1S/C22H25N5O/c1-26(2)15-13-23-20(28)12-7-14-27-19-11-6-3-8-16(19)21-22(27)25-18-10-5-4-9-17(18)24-21/h3-6,8-11H,7,12-15H2,1-2H3,(H,23,28)
Standard InChI Key: DRPNSZPVBXSMHF-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
35.2534 -24.9986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2522 -25.8181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9603 -26.2271 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9585 -24.5897 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6671 -24.9950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6679 -25.8140 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.3764 -26.2211 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.3708 -24.5848 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.0799 -24.9881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0875 -25.8072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.8689 -26.0531 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.8566 -24.7278 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3420 -25.3861 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1529 -25.2941 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4794 -24.5444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9889 -23.8859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1797 -23.9813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.1294 -26.8276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.9305 -26.9893 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1910 -27.7638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9920 -27.9255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.2525 -28.7001 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.5325 -27.3126 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.0536 -28.8617 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.3141 -29.6363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.1152 -29.7979 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.3757 -30.5725 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.6557 -29.1850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 10 2 0
9 8 2 0
8 5 1 0
9 10 1 0
10 11 1 0
11 13 1 0
12 9 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
11 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
21 23 2 0
22 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
26 28 1 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 375.48Molecular Weight (Monoisotopic): 375.2059AlogP: 3.20#Rotatable Bonds: 7Polar Surface Area: 63.05Molecular Species: BASEHBA: 5HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.51CX LogP: 2.83CX LogD: 1.69Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.54Np Likeness Score: -1.33
References 1. Klimenko K, Lyakhov S, Shibinskaya M, Karpenko A, Marcou G, Horvath D, Zenkova M, Goncharova E, Amirkhanov R, Krysko A, Andronati S, Levandovskiy I, Polishchuk P, Kuz'min V, Varnek A.. (2017) Virtual screening, synthesis and biological evaluation of DNA intercalating antiviral agents., 27 (16): [PMID:28666733 ] [10.1016/j.bmcl.2017.06.035 ]